Results 101 to 110 of about 83,920 (307)

Quality‐adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway

International Journal of Cancer, EarlyView.
What's New? Although mammographic screening can reduce breast cancer mortality and extend life, some studies have found a negative impact on net quality‐adjusted life years (QALYs). Here, the authors estimated net QALYs associated with biennial mammographic screening for women aged 50–69 years in Norway under various scenarios.
Rick Groeneweg, Nicolien T. van Ravesteyn, Lindy M. Kregting, Giske Ursin, Solveig Hofvind, Nataliia Moshina   +5 more
wiley   +1 more source

Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain

International Journal of Cancer, EarlyView.
What's New? Breast cancer comprises a heterogeneous group of diseases with differing features and survival outcomes. In particular, survival is affected by socioeconomic status, though age‐specific patterns remain unknown. Here, the authors examined differences in breast cancer incidence and survival specifically among young women in the Community of ...
Candela Pino‐Rosón, Sonia Ávila‐Arroyo, David Parra‐Blázquez, María J. Soto Zabalgogeazcoa, Daniel Moñino, Raquel López‐González, Clotilde Sevilla‐Hernández, Cristina González‐Blázquez, Miguel Martín, Nuria Aragonés   +9 more
wiley   +1 more source

Supplementary Movie 3 from Fibroblast Hepatocyte Growth Factor Promotes Invasion of Human Mammary Ductal Carcinoma <i>In situ</i>

, 2023
Christopher Jedeszko, Bernadette C. Victor, Izabela Podgorski, Bonnie F. Sloane   +3 more
openalex   +1 more source

Challenges in the future of cancer screening

International Journal of Cancer, EarlyView.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

Triple Viral Infections in Advanced Breast Cancer: Insights from a Three-Case Report and Literature Review

Diagnostics
Background and clinical significance: Viral infections are typically considered contributing or secondary factors in the development of breast cancer. Case presentation: This case report presents three instances of advanced breast cancer associated with ...
Ashraf I. Khasawneh, Nisreen Himsawi, Mohammed Alorjani, Hadeel Al-Momani, Uruk Shahin, Ashraf Sammour, Tareq Saleh, Hafez Al-Momani, Rame Khasawneh, Sofian Al Shboul   +9 more
doaj   +1 more source

The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project [PDF]

, 2022
Abeer M. Shaaban, Bridget Hilton, Karen Clements, David Dodwell, Nisha Sharma, Cliona Kirwan, Elinor J. Sawyer, Anthony Maxwell, Matthew Wallis, Hilary Stobart, Senthurun Mylvaganam, Janet Litherland, Samantha Brace-McDonnell, Joanne Dulson-Cox, Olive Kearins, Elena Provenzano, Ian O. Ellis, Sarah E. Pinder, Alastair M. Thompson   +18 more
openalex   +1 more source

Lymph‐based liquid biopsy: Current progress and future potential

Interdisciplinary Medicine, EarlyView.
Recent evidence under the revised Starling principle indicates that lymph‐based liquid biopsies may offer superior diagnostic performance over blood‐based counterparts in certain clinical scenarios, such as early‐stage solid tumor detection. Currently, various biomarkers within the lymphatic system show significant diagnostic potential for a range of ...
Dongdong Liu, Leheng Cheng, Xiaolin Hu, Sergio Bernardini, Hong Zhang, Ling Zhu, Yang Luo   +6 more
wiley   +1 more source

The loss of expression of the tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery [PDF]

, 2002
Michael J. Yunes, D.E. Wazer, Linda Bornstein, Stephen P. Naber, Vimla Band   +4 more
openalex   +1 more source

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression [PDF]

, 2023
Stefan J. Hutten, Roebi de Bruijn, Catrin Lutz, Madelon Badoux, Timo Eijkman, Chao Xue, Marta Ciwinska, Michael Sheinman, Hendrik A. Messal, Andrea Herencia-Ropero, Petra Kristel, Lennart Mulder, Rens van der Waal, Joyce Sanders, Mathilde M. Almekinders, Alba Llop‐Guevara, Helen Davies, Matthijs J. van Haren, Nathaniel I. Martin, Fariba Behbod, Serena Nik‐Zainal, Violeta Serra, Jacco van Rheenen, Esther H. Lips, Lodewyk F.A. Wessels, Jelle Wesseling, Colinda L. G. J. Scheele, Jos Jonkers   +27 more
openalex   +1 more source

Organoids and organ‐on‐a‐chip models for investigating the pathophysiology of the human reproductive system

Interdisciplinary Medicine, EarlyView.
Organoids and organ‐on‐a‐chips are advancing reproductive system research. In the female reproductive system, applications include cancer organoid models, placental chips, and hormone simulation models. For the male reproductive system, research focuses on drug resistance mechanisms, co‐culture platforms, and infertility studies. These refined in vitro
Hongqi Zhang, Shiwen Deng, Fangfang Jin, Jiayao Qu, Xiang Fan, Peng Chen, Xinrong Fan   +6 more
wiley   +1 more source